Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Human Umbilical Vein Endothelial Cells (ID# 7645)
Peptide
Human Umbilical Vein Endothelial Cells
Cells
N/A nM (reported value)
N/A
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
NH2-CysGlyLysArgLys-COOH
5
600.85
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Agemy et al. "Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma." PNAS, doi: 10.1073/pnas.1114518108.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.